Reversible optic neuropathy associated with low-dose methotrexate therapy

Journal of Neuro-Ophthalmology

Volumn 25, Issue 2, 2005, Pages 109-112

  Clare, Gerry ^a   Colley, Stephen ^a   Kennett, Robin ^a   Elston, John S ^a  

^a OXFORD EYE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYANOCOBALAMIN; FOLIC ACID; METHOTREXATE;

AGED; ARTICLE; CASE REPORT; CENTRAL SCOTOMA; CLINICAL FEATURE; COLOR VISION DEFECT; DISEASE COURSE; DRUG MECHANISM; DRUG WITHDRAWAL; EVOKED VISUAL RESPONSE; FEMALE; FOLIC ACID DEFICIENCY; HUMAN; LOW DRUG DOSE; OPTIC NERVE DISEASE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; VISUAL ACUITY; VITAMIN BLOOD LEVEL;

AGED; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; COLOR VISION DEFECTS; EVOKED POTENTIALS, VISUAL; FEMALE; FOLIC ACID; HUMANS; METHOTREXATE; OPTIC NERVE DISEASES; SCOTOMA; VISUAL FIELDS;

EID: 20344376922     PISSN: 10708022     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.WNO.0000166061.73483.CE     Document Type: Article

References (16)

1. Scott JM. Folate and vitamin B12. Proc Nutr Soc 1999;58:441-8.
2. Zijno A, Andreoli C, Leopardi P, Marcon, F, Rossi S, Caiola S, Verdina A, Galati R, Cafolla A, Crebelli R. Folate status, metabolic genotype, and biomarkers of genotoxicity in healthy subjects. Carcinogenesis 2003;24:1097-103.
3. Chan ES and Cronstein BN. Molecular action of methotrexate in inflammatory diseases. Arthritis Res 2002;4:266-73.
4. Endresen GK, Husby G. Folate supplementation during methotrexate treatment of patients with rheumatoid arthritis: an update and proposals for guidelines. Scand J Rheumatol 2001;30:129-34.
5. van Ede AE, Laan RF, Blom HJ, Boers GH, Haagsma CJ, Thomas CM, de Boo TM, van de Putte LBA. Homocysteine and folate status in methotrexate-treated patients with rheumatoid arthritis. Rheumatology 2002;41:658-65.
6. Shelnutt KP, Kauwell GP, Chapman CM, Gregory JF 3rd, Maneval DR, Browdy AA, Theriaque DW, Bailey LB. Folate status reponse to controlled folate intake is affected by the methylenetetrahydrofolate reductase 677C→T polymorphism in young women. J Nutr 2003; 133:4107-11.
7. Kim JM, Lee H, Chang N. Hyperhomocysteinemia due to short-term folate deprivation is related to electron microscopic changes in the rat brain. J Nutr 2002;132:3418-21.
8. Ho PI, Ashline D, Dhitavat S, Ortiz D, Collins SC, Shea TB, Rogers E. Folate deprivation induces neurodegeneration: roles of oxidative stress and increased homocysteine. Neurobiol Dis 2003; 14:32-42.
9. Carelli V, Ross-Cisneros FN, Sadun AA. Optic nerve degeneration and mitochondrial dysfunction: genetic and acquired optic neuropathies. Neurochem Int 2002;40:573-84.
10. Leeb BF, Witzmann G, Ogris E, Studnicka-Benke A, Andel I, Schweitzer H, Smolen JS. Folic acid and cyanocobalamin levels in serum and erythrocytes during low-dose methotrexate therapy of rheumatoid arthritis and psoriatic arthritis patients. Clin Exp Rheumatol 1995;13:459-63.
11. Yxfeldt A, Wallberg-Jonsson S, Hultdin J, Rantapaa-Dahlqvist S. Homocysteine in patients with rheumatoid arthritis in relation to inflammation and B-vitamin treatment. Scand J Rheumatol 2003; 32:205-10.
12. Golnik KC, Schaible ER. Folate-responsive optic neuropathy. J Neuroophthalmol 1994;14:163-69.
13. Chisholm IA. Serum cobalamin and folate in the optic neuropathy associated with tobacco smoking. Can J Ophthalmol 1978;13:105-9.
14. Hsu CT, Miller NR, Wray ML. Optic neuropathy from folic acid deficiency without alcohol abuse. Ophthalmologica 2002;216:65-7.
15. Johansson BA. Visual field defects during low-dose methotrexate therapy. Doc Ophthalmol 1992;79:91-4.
16. Balachandran C, McCluskey PJ, Champion GD, Halmagyi GM. Methotrexate-induced optic neuropathy. Clin Experiment Ophthalmol 2002;30:440-1.